World Federation of Societies of Biological Psychiatry (WFSBP)Guidelines for Biological Treatment of Schizophrenia, Part 1: acute treatment of schizophrenia (2005)
- Authors:
- Autor USP: GATTAZ, WAGNER FARID - FM
- Unidade: FM
- Subjects: DOENÇA AGUDA; MEDICINA BASEADA EM EVIDÊNCIAS; DIRETRIZES; ESQUIZOFRENIA (TERAPIA)
- Language: Inglês
- Imprenta:
- Source:
- Título: World Journal of Biological Psychiatry
- ISSN: 1562-2975
- Volume/Número/Paginação/Ano: v. 6, n. 3, p. 132-191, 2005
-
ABNT
FALKAI, Peter et al. World Federation of Societies of Biological Psychiatry (WFSBP)Guidelines for Biological Treatment of Schizophrenia, Part 1: acute treatment of schizophrenia. World Journal of Biological Psychiatry. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.wfsbp.org/fileadmin/pdf/world-journal-public/2005%20Vol%206_3.pdf. Acesso em: 25 jan. 2026. , 2005 -
APA
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., & Möller, H. -J. (2005). World Federation of Societies of Biological Psychiatry (WFSBP)Guidelines for Biological Treatment of Schizophrenia, Part 1: acute treatment of schizophrenia. World Journal of Biological Psychiatry. London: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.wfsbp.org/fileadmin/pdf/world-journal-public/2005%20Vol%206_3.pdf -
NLM
Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller H-J. World Federation of Societies of Biological Psychiatry (WFSBP)Guidelines for Biological Treatment of Schizophrenia, Part 1: acute treatment of schizophrenia [Internet]. World Journal of Biological Psychiatry. 2005 ; 6( 3): 132-191.[citado 2026 jan. 25 ] Available from: http://www.wfsbp.org/fileadmin/pdf/world-journal-public/2005%20Vol%206_3.pdf -
Vancouver
Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller H-J. World Federation of Societies of Biological Psychiatry (WFSBP)Guidelines for Biological Treatment of Schizophrenia, Part 1: acute treatment of schizophrenia [Internet]. World Journal of Biological Psychiatry. 2005 ; 6( 3): 132-191.[citado 2026 jan. 25 ] Available from: http://www.wfsbp.org/fileadmin/pdf/world-journal-public/2005%20Vol%206_3.pdf - Atividade de subtipos de 'PLA IND. 2' em neurônios primários mantidos em cultura
- Inibição da fosfolipase 'A IND. 2' e hiperfosforilação da proteína Tau em culturas primárias de neurônios corticais e hipocampais
- GSK3beta em plaquetas de indivíduos com doença de Alzheimer e comprometimento cognitivo leve
- Glycogen synthase kinase-313 activity and cognitive functioning in patients with bipolar I disorder
- Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline
- Childhood meningitis and adults schizophrenia
- Lithium Monotherapy Increases Nitric Oxide Levels During Depressive Episodes in Bipolar Disorder
- Phospholipase A2 activity in rat embryonic brain and in primary cultures of cortical neurons
- Reabilitação profissional: emprego assistido
- Phospholipase A2, and the hypofrontality hypothesis of schizophrenia
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
